H.R. 9509

H.R. 9509: To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act with respect to the coverage of kidney disease education services under Medicare and private health insurance.

Introduced Suzan DelBene (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9509 aims to enhance coverage for kidney disease education services under Medicare and private health insurance. This means that individuals with kidney disease or at risk of developing it would have better access to educational resources and support that can help them manage their health and treatment options.

Positive Media Summary

Supporters of H.R. 9509 have praised the bill for its potential to improve patient outcomes by ensuring that individuals receive essential education about kidney disease. Many health advocates believe that better education can lead to more informed patients, reducing complications and healthcare costs in the long run.

Negative Media Summary

Critics of H.R. 9509 argue that the bill may impose additional costs on health insurance providers and could lead to increased premiums for consumers. Some have expressed concerns about the effectiveness of education services compared to direct medical interventions, questioning whether this approach will yield significant health benefits.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

While there are no direct industry overlaps between the bill's subject matter—focused on kidney disease education services—and the sponsor's top donor industries, the lobbying activity in this area raises some concerns. Notably, RESPOND-US, which has contributed $140,000, is involved in healthcare and could have interests aligned with the bill's provisions. Additionally, GINKGO BIOWORKS, INC. contributed $60,000 and operates in the biotech space, which may intersect with kidney disease education and treatment. These contributions suggest a potential influence on the legislative process, although the absence of direct donor industry overlaps mitigates the risk somewhat. Voters should be aware that while the bill aims to improve healthcare services, the financial interests of lobbyists could sway its implementation.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
RESPOND-US CORNERSTONE GOVERNMENT AFFAIRS, INC. $140,000
SILVERLINING ALPINE GROUP PARTNERS, LLC. $80,000
MEDLINE CORNERSTONE GOVERNMENT AFFAIRS, INC. $80,000
GINKGO BIOWORKS, INC. CORNERSTONE GOVERNMENT AFFAIRS, INC. $60,000
PEABODY ENERGY CORPORATION CORNERSTONE GOVERNMENT AFFAIRS, INC. $50,000
LUFTHANSA GERMAN AIRLINES CAPITOL POINT GROUP, LLC $50,000
MERIDIAM INFRASTRUCTURE CAPITOL POINT GROUP, LLC $40,000
LEO TECHNOLOGIES BUTLER SNOW LLP $30,000
MAXIMUS BRICK STREET STRATEGY $30,000
JOHNSON & JOHNSON BRICK STREET STRATEGY $30,000
OCCIDENTAL PETROLEUM CORPORATION GTB PARTNERS $20,000
CHAMBERS COUNTY DEVELOPMENT AUTHORITY BUTLER SNOW LLP $15,000
HEARTH, PATIO & BARBECUE ASSOCIATION HEARTH, PATIO & BARBECUE ASSOCIATION $15,000
THE UNIVERSITY OF WEST ALABAMA BUTLER SNOW LLP $12,000
BASIS PATH BUTLER SNOW LLP undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Suzan DelBene, ranked by total contributions.

Health Professionals $800,000,000
Individuals: $800,000,000 PACs: $0
Retired $250,000,000
Individuals: $250,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us